These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2039437)

  • 1. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
    Car BD; Baggiolini M; Walz A
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets.
    Cohen AB; Stevens MD; Miller EJ; Atkinson MA; Mullenbach G
    Am J Physiol; 1992 Aug; 263(2 Pt 1):L249-56. PubMed ID: 1387511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
    Walz A; Baggiolini M
    J Exp Med; 1990 Feb; 171(2):449-54. PubMed ID: 2406364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
    Walz A; Dewald B; von Tscharner V; Baggiolini M
    J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III.
    Brandt E; Van Damme J; Flad HD
    Cytokine; 1991 Jul; 3(4):311-21. PubMed ID: 1873479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3.
    Padrines M; Wolf M; Walz A; Baggiolini M
    FEBS Lett; 1994 Sep; 352(2):231-5. PubMed ID: 7925979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
    Härter L; Petersen F; Flad HD; Brandt E
    J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G.
    Schiemann F; Grimm TA; Hoch J; Gross R; Lindner B; Petersen F; Bulfone-Paus S; Brandt E
    Blood; 2006 Mar; 107(6):2234-42. PubMed ID: 16317101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
    Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
    Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
    Ehlert JE; Ludwig A; Grimm TA; Lindner B; Flad HD; Brandt E
    Blood; 2000 Nov; 96(9):2965-72. PubMed ID: 11049972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and bioactivity of recombinant human CTAP-III and NAP-2.
    Proudfoot AE; Peitsch MC; Power CA; Allet B; Mermod JJ; Bacon K; Wells TN
    J Protein Chem; 1997 Jan; 16(1):37-49. PubMed ID: 9055206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
    Ehlert JE; Gerdes J; Flad HD; Brandt E
    J Immunol; 1998 Nov; 161(9):4975-82. PubMed ID: 9794434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
    Malkowski MG; Lazar JB; Johnson PH; Edwards BF
    J Mol Biol; 1997 Feb; 266(2):367-80. PubMed ID: 9047370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of serine proteinases with pNiXa, a serpin of Xenopus oocytes and embryos.
    Kotyza J; Varghese AH; Korza G; Sunderman FW
    Biochim Biophys Acta; 1998 Feb; 1382(2):266-76. PubMed ID: 9540798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
    J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration.
    Schenk BI; Petersen F; Flad HD; Brandt E
    J Immunol; 2002 Sep; 169(5):2602-10. PubMed ID: 12193731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of glucose transporters by connective tissue activating peptide-III isoforms.
    Tai PK; Liao JF; Hossler PA; Castor CW; Carter-Su C
    J Biol Chem; 1992 Sep; 267(27):19579-86. PubMed ID: 1527075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation.
    Plescia J; Altieri DC
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):873-9. PubMed ID: 8920993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    Gibson TL; Cohen P
    Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G.
    Speer CP; Pabst MJ; Hedegaard HB; Rest RF; Johnston RB
    J Immunol; 1984 Oct; 133(4):2151-6. PubMed ID: 6088632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.